Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
6.410
Zitationen
15
Autoren
2010
Jahr
Abstract
Tumor HPV status is a strong and independent prognostic factor for survival among patients with oropharyngeal cancer. (ClinicalTrials.gov number, NCT00047008.)
Ähnliche Arbeiten
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
1993 · 15.645 Zit.
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 · 5.074 Zit.
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
2016 · 4.943 Zit.
Head and neck squamous cell carcinoma
2020 · 3.825 Zit.
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
2008 · 3.675 Zit.
Autoren
Institutionen
- The University of Texas MD Anderson Cancer Center(US)
- RTOG Foundation(US)
- Huntsman Cancer Institute(US)
- Centre Hospitalier de l’Université de Montréal(CA)
- Johns Hopkins University(US)
- Vanderbilt University(US)
- University Medical Center(US)
- Wayne State University(US)
- Thomas Jefferson University Hospital(US)
- University of Louisville(US)
- University of Cincinnati Medical Center(US)
- The Ohio State University(US)